Published in
Elsevier, European Journal of Cancer, (86), p. 186-196, 2017
DOI: 10.1016/j.ejca.2017.08.027
Links
Tools
A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer
Journal article published in 2017 by
Jean-Charles Soria,
Alex A. Adjei,
Rastilav Bahleda,
Benjamin Besse,
Charles Ferte,
David Planchard,
Jing Zhou,
Joseph Ware,
Kari Morrissey,
Geetha Shankar,
Wei Lin,
Jennifer L. Schutzman,
Grace K. Dy,
Harry J. M. Groen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 